Rocket Pharmaceuticals
Price & Volume
Stats
See more52W Range | $2.19-$9.84 |
Market Cap | $431.8M |
Shares Short | 13M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.25 |
News
See moreYahoo Finance • 3 months ago
Fanconi Anemia Market Research Report 2025-2035: Competitive Growth Driven by Rocket Pharmaceuticals, Foresee, Merck, and Abeona as Gene Therapy and CRISPR-Based Innovations Expand
Yahoo Finance • 4 months ago
Rocket Pharmaceuticals, Inc. Q3 Loss Decreases, Beats Estimates
Yahoo Finance • 4 months ago
ROCKET ALERT: Bragar Eagel & Squire, P.C. is Investigating Rocket Pharmaceuticals, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Yahoo Finance • 4 months ago
Prothena Corporation plc (PRTA): A Bull Case Theory
About
CEO | Dr. Gaurav D. Shah M.D. |
Address | 9 Cedarbrook Drive, Cranbury, NJ, United States, 08512 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 299 |
